Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.64 Million | 960 Thousand | -1.08 Million | -3.68 Million | 364 Thousand | -730 Thousand |
| Net Income | -5.01 Million | -8.96 Million | -4.72 Million | -5.53 Million | -3.23 Million | -5.45 Million |
| Depreciation & Amortization | 4.32 Million | 3.46 Million | 3.69 Million | 3.13 Million | 1.25 Million | 1.63 Million |
| Deferred income taxes | - | - | - | 1000.00 | - | 1000.00 |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.26 Million | 2.28 Million | -405 Thousand | -2.1 Million | 2.24 Million | 3.02 Million |
| Other non-cash items | 314 Thousand | 4.17 Million | 344 Thousand | 820 Thousand | 100 Thousand | 70 Thousand |
| Investing Cash Flow | -1.47 Million | -3.09 Million | -2.69 Million | 4.62 Million | -2.29 Million | -3.22 Million |
| Investments in PPE | -2.72 Million | -2.59 Million | -5.88 Million | -3.08 Million | -3.37 Million | -3.23 Million |
| Acquisitions | 221 Thousand | 7.95 Million | 3.83 Million | 7.7 Million | 1.01 Million | 134 Thousand |
| Investment purchases | - | -2.59 Million | -1.34 Million | -7.7 Million | -1.01 Million | - |
| Sales/Maturities of investments | - | -7.95 Million | 165 Thousand | 2000.00 | 20 Thousand | 4000.00 |
| Other Investing Activities | 1.24 Million | 2.09 Million | 531 Thousand | 7.7 Million | 1.06 Million | 8000.00 |
| Financing Cash Flow | 3.48 Million | 3.07 Million | 6.24 Million | 1.04 Million | 3.39 Million | 259 Thousand |
| Debt repayment | -1.98 Million | -8.6 Million | -2.88 Million | -7.32 Million | -674 Thousand | -985 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -17 Thousand |
| Common Stock Issuance | 36 Thousand | 5.86 Million | - | - | 1000.00 | - |
| Other Financing Activities | - | 5.82 Million | 9.13 Million | 8.36 Million | 4.07 Million | 1.26 Million |
| Accounts receivables | 288 Thousand | 870 Thousand | -285 Thousand | 2.56 Million | -198 Thousand | 1.99 Million |
| Accounts payables | -1.33 Million | 1.96 Million | 1.75 Million | -3.32 Million | 1.97 Million | 1.8 Million |
| Inventory | -1.15 Million | -527 Thousand | 146 Thousand | -3.06 Million | 473 Thousand | -975 Thousand |
| Other working capital | -104 Thousand | -18 Thousand | -2.02 Million | 1.71 Million | 1000.00 | 3.99 Million |
| Cash at beginning of period | 4.38 Million | 4.13 Million | 1.67 Million | -301 Thousand | -1.76 Million | 1.92 Million |
| Cash at end of period | 4.75 Million | 4.38 Million | 4.13 Million | 1.67 Million | -301 Thousand | -1.76 Million |
| Capital Expenditure | -2.72 Million | -2.59 Million | -5.88 Million | -3.08 Million | -3.37 Million | -3.23 Million |
| Effect of forex changes on cash | 1000.00 | -689 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 362 Thousand | 252 Thousand | 2.46 Million | 1.97 Million | 1.46 Million | -3.69 Million |
| Free Cash Flow | -4.36 Million | -1.63 Million | -6.96 Million | -6.77 Million | -3.01 Million | -3.96 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.43 Million | -13.54 Million | -5.01 Million | 3.77 Million | 1888.00 | -8.96 Million |
| Depreciation & Amortization | 1.28 Million | 1.2 Million | 4.32 Million | 1.13 Million | 202.50 | 3.46 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.04 Million | 2.07 Million | -1.26 Million | -3.33 Million | -1115.50 | 2.28 Million |
| Other non-cash items | 64 Thousand | 11.35 Million | 314 Thousand | 2.57 Million | -1861.00 | 4.17 Million |
| Investing Cash Flow | -1.97 Million | -154 Thousand | -1.47 Million | -1.28 Million | -647.50 | -3.09 Million |
| Investments in PPE | -1.89 Million | -1.37 Million | -2.72 Million | -1.34 Million | -674.00 | -2.59 Million |
| Acquisitions | -72 Thousand | 160 Thousand | 221 Thousand | 61 Thousand | - | 7.95 Million |
| Investment purchases | - | - | - | - | - | -2.59 Million |
| Sales/Maturities of investments | - | - | - | - | - | -7.95 Million |
| Other Investing Activities | - | 1.06 Million | 1.24 Million | 26.50 | 26.50 | 2.09 Million |
| Financing Cash Flow | -1.6 Million | 800 Thousand | 3.48 Million | 2.64 Million | 1229.50 | 3.07 Million |
| Debt repayment | -1.6 Million | -800 Thousand | -1.98 Million | -2.64 Million | - | -8.6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3000.00 | - | 36 Thousand | - | - | 5.86 Million |
| Other Financing Activities | 1000.00 | - | - | 1229.50 | 1229.50 | 5.82 Million |
| Accounts receivables | -3.04 Million | 2.06 Million | 288 Thousand | -1.77 Million | -889.00 | 870 Thousand |
| Accounts payables | 1.29 Million | -230 Thousand | -1.33 Million | -1.1 Million | - | 1.96 Million |
| Inventory | 1.21 Million | -199 Thousand | -1.15 Million | -960 Thousand | -480.00 | -527 Thousand |
| Other working capital | 1.57 Million | 439 Thousand | -104 Thousand | 507 Thousand | 253.50 | -18 Thousand |
| Cash at beginning of period | 4.75 Million | 3.82 Million | 4.38 Million | 4.38 Million | -303.69 Thousand | 4.13 Million |
| Cash at end of period | 2.14 Million | 4.75 Million | 4.75 Million | 3.82 Million | -304 Thousand | 4.38 Million |
| Capital Expenditure | -1.89 Million | -1.37 Million | -2.72 Million | -1.34 Million | -674.00 | -2.59 Million |
| Effect of forex changes on cash | - | - | 1000.00 | 45 Thousand | - | -689 Thousand |
| Net cash flow / Change in cash | -2.61 Million | 932 Thousand | 362 Thousand | -563 Thousand | -304.00 | 252 Thousand |
| Free Cash Flow | -936 Thousand | -1.05 Million | -4.36 Million | -3.31 Million | -1560.00 | -1.63 Million |
3551
SVTRF
CVW
600586
600621
SIGN